NEU 2.90% $19.86 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-744

  1. 1,390 Posts.
    lightbulb Created with Sketch. 297
    So based on that analysis, seems like E&P are valuing NNZ-2591 - only once successful across ALL FOUR indications - at approx $3.6B.

    So that the MAX value of the asset !! LOL !

    Just another example of how Broking houses get the Bio sector totally wrong !!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.